Clinical Trial Update: Clinical Study of CLL-1 CAR-T in the Treatment of Children With R/R AML [EARLY_Phase 1]

View source ↗

Summary

This early phase 1 clinical trial evaluates a CAR-T therapy targeting CLL-1 (CLEC12A) in children with relapsed or refractory acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CLL-1 CAR-T

Snippet

Sponsor: First Affiliated Hospital of Guangxi Medical University | Conditions: AML (Acute Myeloid Leukemia), CAR-T | EARLY_Phase 1 | Status: NOT_YET_RECRUITING